Skip to main content

RxSight, Inc.

For the period ended Mar 31, 2026. Filed May 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 6, 2026

RXST$4.86+7.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(In thousands, except share and per share amounts)

March 31,December 31,
20262025
(Unaudited)
Assets
Current assets:
Cash and cash equivalents$17,573$19,949
Short-term investments200,307208,179
Accounts receivable, net22,44323,383
Inventories, net34,86931,559
Prepaid and other current assets4,0334,389
Total current assets279,225287,459
Property and equipment, net13,23213,056
Operating leases right-of-use assets9,7609,959
Restricted cash750750
Other assets1,026590
Total assets$303,993$311,814
Liabilities and stockholders' equity
Current liabilities:
Accounts payable$7,124$5,296
Accrued expenses and other current liabilities18,74819,795
Lease liabilities1,5041,162
Total current liabilities27,37626,253
Long-term lease liabilities9,3229,878
Total liabilities36,69836,131
Commitments and contingencies (Note 8)
Stockholders' equity:
Common stock, $0.001 par value, 900,000,000 shares authorized, 41,384,120 shares issued and outstanding as of March 31, 2026 and 41,242,005 shares issued and outstanding as of December 31, 20254141
Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding——
Additional paid-in capital944,244936,628
Accumulated other comprehensive (loss) income(67)53
Accumulated deficit(676,923)(661,039)
Total stockholders' equity267,295275,683
Total liabilities and stockholders' equity$303,993$311,814
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.